Activation of natural killer (NK) cell cytotoxicity requires adhesion and formation of a conjugate with a susceptible target cell, followed by actin polymerization, and polarization of the microtubule organizing center (MTOC) and cytolytic granules to the NK cell immune synapse. Here, by using the YTS NK cell line as a model, CD28 is shown to be an activating receptor. It signals cytotoxicity in a process dependent on phosphoinositide-3 kinase activation, leading to sustained extracellular signal-regulated kinase 2 (ERK2) phosphorylation. ERK and phospho-ERK localize to microtubule filaments. Neither conjugation with targets nor actin polymerization is affected by blocking ERK2 activation. However, both polarization of the MTOC and cytolytic granules to the synaptic region and NK cell cytotoxicity are strongly reduced by blocking ERK2 activation. A role for the CD28͞CD80 interaction in cytotoxicity of human peripheral NK cells also was established. By contrast, lymphocyte function-associated antigen 1 (LFA-1) ligation transduces only a transient ERK2 activation and fails to induce killing in YTS cells. Thus, in YTS cells, a CD28 signal is used to polarize the MTOC and cytolytic granules to the NK cell immune synapse by stimulating sustained ERK2 activation.
Activation of natural killer (NK) cell cytotoxicity requires adhesion and formation of a conjugate with a susceptible target cell, followed by actin polymerization, and polarization of the microtubule organizing center (MTOC) and cytolytic granules to the NK cell immune synapse. Here, by using the YTS NK cell line as a model, CD28 is shown to be an activating receptor. It signals cytotoxicity in a process dependent on phosphoinositide-3 kinase activation, leading to sustained extracellular signal-regulated kinase 2 (ERK2) phosphorylation. ERK and phospho-ERK localize to microtubule filaments. Neither conjugation with targets nor actin polymerization is affected by blocking ERK2 activation. However, both polarization of the MTOC and cytolytic granules to the synaptic region and NK cell cytotoxicity are strongly reduced by blocking ERK2 activation. A role for the CD28͞CD80 interaction in cytotoxicity of human peripheral NK cells also was established. By contrast, lymphocyte function-associated antigen 1 (LFA-1) ligation transduces only a transient ERK2 activation and fails to induce killing in YTS cells. Thus, in YTS cells, a CD28 signal is used to polarize the MTOC and cytolytic granules to the NK cell immune synapse by stimulating sustained ERK2 activation.
actin polymerization ͉ cytotoxic granules ͉ microtubule organizing center polarization ͉ cytotoxicity N atural killer (NK) cells are granular lymphocytes that show cytotoxicity in response to tumor cells and viral infection (1) . Various surface molecules can serve as activating receptors, including members of the NKG2 family (NKG2C, NKG2D, and NKG2E), natural cytotoxicity receptor (NCR) family (NKp30, NKp44, and NKp46), integrin family [e.g., lymphocyte functionassociated antigen 1 (LFA-1), CR3, and CR4], and others (e.g., CD2, CD244, and CD16) (2) . Interestingly, CD28, a T cell costimulatory receptor for B7 molecules, has also been implicated in inducing NK cytotoxicity. Transfected mouse P815 cells expressing human B7 ligands (CD80, CD86), compared with nontransfected cells, have been shown to dramatically increase the cytolytic activity of human peripheral NK (pNK) cell lines and NK cell clones (3) (4) (5) . The signaling capacity of CD28 is mediated mainly through recruiting phosphoinositide-3 kinase (PI3K) to the YxxM motif in its cytoplasmic domain after its tyrosine phosphorylation (6, 7) . However, the exact role of CD28 in activating NK cell cytotoxicity is not clear. NK cells also possess adhesion molecules LFA-1 (␣L␤2, CD11aCD18), as well as ␣4␤1 and ␣6␤1. LFA-1 can induce actin polymerization in T lymphocytes (8, 9) , but its role in NK cell cytotoxicity is not yet fully understood.
In a contact-dependent manner, NK cells ''inject'' cytolytic granules, containing perforin and granzymes, into target cells and induce target cell death (10) . The cytotoxicity process is orchestrated by two cytoskeletal elements: filamentous actin (FA) and microtubules (MT). Studies have shown that both of them undergo transient and dynamic structural remodeling during NK cell cytotoxicity (11) . FA accumulates in the NK cell immune synapse (NKIS), followed by the directional translocation of the MT organizing center (MTOC) toward the NKIS (11, 12) . Perturbation of either FA or MT completely eliminates cytolytic activity of human NK cells. Studies on MT have suggested that the polarization of the MTOC is responsible for the polarization of cytolytic granules inside the cytotoxic lymphocyte, but dispensable for immune synapse formation (13) . Granule polarization is a critical step in cytotoxicity. In NK cells, a pivotal signaling pathway from PI3K via Rac, PAK1, MEK to extracellular signal-regulated kinase (ERK) has been shown to be involved in triggering the polarization of cytolytic granules (14) . By using a specific inhibitor of MEK1͞2 [a mitogen-activated protein kinase (MAPK) kinase], polarization of the cytolytic granules to the NKIS was dramatically impaired, supporting the involvement of ERK (a MAPK) in this process (15) . However, the mechanism by which ERK signaling regulates granule translocation was not investigated. Interestingly, the polarization of cytolytic granules in NK cells requires intact MT filaments (10) . Therefore, ERK signaling might be able to modulate the movement of the MTOC and thus granule transport in the cytotoxicity of NK cells.
In this work, the YTS NK tumor cell line is used to understand the roles and relation of CD28 and ERK. CD28 is an activating receptor that stimulates the cytotoxicity of YTS cells (as well as human pNK cells), whereas LFA-1 fails to do so. Crosslinking of CD28 and LFA-1 results in different patterns of ERK2 phosphorylation. ERK is found to localize to MT. Blocking ERK2, but not ERK1, activation leads to impaired polarization of the MTOC and cytolytic granules, thus leading to the defect in NK cell cytotoxicity. The capacity to induce NK cell killing by CD28 corresponds to its signaling strength to phosphorylate ERK2. Human pNK cells express various activating receptors (including CD28) to mediate cytotoxicity signals (2, 4) . CD56 ϩ CD3 Ϫ YTS cells, a subclone of a widely used NK cell tumor line YT (16, 17) , were screened for the expression of NK activating receptors. Interestingly, LFA-1 and CD28, two costimulatory receptors for T lymphocytes, were highly expressed, but relatively low levels of other natural cytotoxicity receptors (NKp46, NKp44, NKp30, and NKG2D) were found (Fig. 1A) . Three target cell lines were tested for the existence of human CD54 [intercellular adhesion molecule-1 (ICAM-1)], and CD102 (ICAM-2) (ligands of LFA-1), and for CD80 (B7.1) and CD86 (B7.2) (ligands of CD28). The human MHC I-negative Epstein-Barr virus-transformed B cell line 721.221 expressed a high level of B7.1. The human erythroleukemia line K562 highly expressed ICAM-1 but little or no B7.1 or B7.2. The murine mastocytoma cell line P815 does not have any of the human ligands (Fig. 1B) . YTS cells kill 721.221 cells, but not K562 cells or P815 cells (Fig. 1C) . The correspondence of expression of CD80 with the susceptibility of these target cells suggested that CD28 signaling is critical for the cytolytic activity of YTS cells.
Imaging studies of the immune synapse between YTS and 721.221 cells showed that both CD28 and CD18 (the ␤ subunit of LFA-1) accumulated in the synapse area ( Fig. 2A) , indicating the important roles that CD28 and LFA-1 play in signaling in NKIS formation. Is the CD28 signal or the LFA-1 signal sufficient to activate YTS cytotoxicity independently? To address this question, P815 cell lines overexpressing ICAM-1, ICAM-2, B7.1, or B7.2 and K562 cells expressing the B7 molecules were constructed by stable transfection (see Fig. 7 , which is published as supporting information on the PNAS web site, with the expression levels indicated in the graph). Interestingly, only the B7-expressing target cells were susceptible to cytolysis by YTS, with CD80 and CD86 inducing a similar level of cytotoxicity (Fig. 2B) . Killing of B7.1-and B7.2-transfected cells could be completely inhibited with anti-CD28 mAb (Fig. 2C) . The interaction between LFA-1 and ICAM-1 or -2, however, was unable by itself to stimulate a cytotoxic signal. Two pieces of evidence support this finding. First, the introduced expression of ICAM ligands on P815 cells did not activate cytotoxicity. Second, K562 cells, with endogenous expression of ICAM ligands, were resistant to killing. However, exogenous expression of B7 ligands in either cell line rendered them susceptible to YTS cytolysis. Therefore, LFA-1 signaling alone was not sufficient to induce YTS cytotoxic activity, whereas signals from CD28 ligation did trigger cytotoxic functions, at least in P815 and K562 cells.
ERK Signaling Is Required for MTOC Polarization and Therefore NK
Cytotoxicity. To study the molecular mechanism underlying the difference between CD28 and LFA-1 functions, a pivotal cytotoxic signaling pathway in NK cells was investigated. Granule polarization in NK cells was reported to be related to the PI3K, ERK1͞2 pathway (15) . MT filaments play a critical role in transporting the granules in NK cells (10) . Therefore, YTS cytotoxicity was further characterized by examining whether ERK1͞2 signaling regulates MT remodeling, thereby regulating granule translocation.
Several chemical inhibitors of the PI3K, MEK1͞2 (a MAPK kinase), and ERK1͞2 (a MAPK) pathway were used: wortmannin (a reversible PI3K inhibitor), LY294002 (an irreversible PI3K inhibitor), PD98059 (blocking MEK1͞2 function), and TAT-MEK13 [which prevents ERK1͞2 from interacting with MEK1͞2 (18), thus blocking the activation of ERK1͞2]. All four of these inhibitors significantly decreased the cytotoxicity of YTS cells (Fig. 3A) . These results were extended with DNA-based transient RNA interference (RNAi) and lentivirus-based stable RNAi. Both were used to specifically knock down either ERK1 or ERK2. Interestingly, knockdown of ERK2 (81% reduction in expression level) decreased the cytotoxic activity of YTS cells (Fig. 3B ), whereas ERK1 RNAi had little effect, despite clearly down-regulating the ERK1 protein (76% reduction in expression level; see Fig. 3B and also Fig. 8 , which is published as supporting information on the PNAS web site). Importantly, an apoptosis detection assay showed that neither the chemical inhibitors nor RNAi treatments caused cell death (see Fig. 9A , which is published as supporting information on the PNAS web site) (indicating that the defect in NK cell cytotoxicity is not due to the impairment of cell survival). These treatments also did not affect conjugation between NK cells and their targets (Fig. 9B) . These results confirm the importance of ERK signaling in NK cytotoxicity and identify ERK2, but not ERK1, as the essential downstream regulator of this pathway.
MTOC and cytolytic granule polarization is a critical step in NK cell cytotoxicity (10) (11) (12) . Therefore, the question of whether ERK2 signaling is required to induce MT remodeling in YTS cells was examined. To this end, immunostaining of the NK cell-target cell conjugates were performed, and the polarization of the MTOC and cytolytic granules to the synapse was observed and counted. In the presence of PD98059, TAT-MEK13, and ERK2 RNAi knockdown (Fig. 4 A and B) , the percentage of polarization of granzyme B (GB) was decreased by half (Fig. 4C) . Importantly, MTOC polarization to the synapse was reduced to a similar extent. Thus, ERK2 plays a specific role in modulating MT function and thus in regulating the translocation of cytolytic granules during YTS cell cytotoxicity.
To examine whether the target of ERK2 activity was MT or cytolytic granules, the distribution of cytoplasmic ERK in NK cells was determined. Interestingly, ERK was observed to precisely colocalize with MT in NK cells. Immunostaining with both pan-ERK-specific (Fig. 4D ) and phospho-ERK-specific (Fig. 4E ) mAb revealed that ERK colocalizes with MT, but not with cytolytic granules. ERK also was found to cofractionate with tubulin in a gel filtration experiment, indicating a physical interaction (ref. 20 and data not shown). Thus, ERK activity may directly regulate MT function.
CD28 Crosslinking, but Not LFA-1 Crosslinking, Induces a Sustained Activation of ERK2. As shown earlier in this work, CD28, but not LFA-1, signaling was sufficient to induce YTS cell cytotoxicity. Also, ERK2 signaling was involved in the cytotoxicity of YTS cells. Therefore, whether ERK2 is selectively activated by the stimulation of CD28, but not by LFA-1, was investigated next. To study this question, the ERK phosphorylation level in YTS cells was examined after crosslinking the surface receptors with specific mAb. Intracellular staining (21) with a mAb specific for phosphorylated ERK revealed that LFA-1 ligation produced a transient ERK phosphorylation, peaking rapidly by 3 min and declining quickly to half maximum in the next 2 min (Fig. 5A) . In contrast, CD28 ligation generated a sustained ERK phosphorylation, peaking at 7 min and reaching half maximum in 15 min. The engagement of both LFA-1 and CD28 signals resulted in prolonged ERK activation. Because the anti-phospho-ERK Ab does not distinguish ERK2 from ERK1, the ERK RNAi knockdown cell lines were used for the same experiment to distinguish the two. ERK1 RNAi knockdown YTS cells, after crosslinking CD28 and LFA-1 together, produced a long-lasting ERK phosphorylation signal, nearly identical to the pattern shown in the wild-type YTS cells (Fig. 5B) . ERK2 RNAi knockdown YTS cells, however, showed a severe decrease of ERK phosphorylation after the same crosslinking. A low level of residual ERK phosphorylation was detected, probably from the remaining endogenous ERK2. Furthermore, Western blots of the total cell lysate revealed that ERK2, but not ERK1, was specifically phosphorylated after the induction (Fig. 5C ). ERK2 previously has been shown to be specifically activated by target-cell-triggered YTS cells (22) . Therefore, CD28 signals, but not LFA-1 signals, result in sustained ERK2 activation in YTS cells. Given the role of ERK2 in modulating MTOC polarization, CD28 ligation appears to trigger the mobility of the MTOC (and cytolytic granules) via an ERK2-mediated pathway. However, LFA-1 crosslinking does not polarize the MTOC, possibly due to its weakness in signaling ERK2 phosphorylation.
CD28, but Not LFA-1, also Stimulated Cytotoxicity of pNK Cells. For comparison, human NK cells were isolated from peripheral blood (pNK). They express CD28, LFA-1, NKG2D, NKp46 (Fig. 6A) , NKp30, NKp44, 2B4, and Mac-1 (data not shown). Nearly all pNK cells examined expressed CD28, although at a lower level than the other receptors studied.
The importance of CD28, whose ability to function as a receptor for cytotoxicity in pNK cells is not generally appreciated (2), was investigated. The four transfected P815 cell lines (expressing the B7.1, B7.2, ICAM-1, or ICAM-2 ligands) were used as targets. Freshly isolated pNK cells did not kill any of the four cell lines (data not shown). After 24 h of IL-2 stimulation, however, pNK cells acquired a moderate cytotoxic activity on P815 cells. This activity was significantly up-regulated by expression of CD28 ligands, B7.1, or B7.2 on P815 cells, but not by LFA-1 ligands, ICAM-1, or ICAM-2 (Table 1) . Further, blocking of the CD28 receptor on pNK cells or the CD80 ligand on P815-CD80 targets completely eliminated the killing (Fig. 6B) . In line with previous reports (3-5), CD28 . FACS analysis was performed to confirm that the CD56 ϩ CD3 Ϫ NK cells were obtained, and the expression of CD28 (with mAb YTH293.2), LFA-1, NKG2D, and NKp46 was verified on the gated population. Although the arbitrary cut-off suggested that 18% of pNK cells were CD28 ϩ (Right Upper), the histogram indicated that nearly all of these cells were CD28 ϩ (Left Lower). (B) Anti-CD28 (clone L293) and anti-CD80 mAbs were used to block in the killing assays to confirm that the killing was specific for the CD28 and CD80 interaction. This result is representative of three independent experiments with pNK isolated from three donors.
signals increased the cytolytic ability of human pNK cells. Thus, similar to the experiments in YTS cells, a CD28 signal is sufficient to mediate the cytotoxicity of pNK cells.
Discussion
Cytolysis mediated by the YTS NK tumor cell line was shown to depend mainly on signals from two surface receptors: CD28 and LFA-1 (cf. also ref. 7). Interestingly, CD28 signaling alone was sufficient to induce killing. pNK cells also were shown to express CD28 (although at a lower level than in the YTS NK tumor cell line) that was able to induce cytotoxicity on recognitions of its CD80 ligand. The importance of CD28 to YTS cytotoxicity also was indicated in another assay system. In long-term cytotoxicity assays with YTS, depending on the culture conditions and effector to target ratio, a small fraction of 721.221 cells were able to persist for multiple days. Intriguingly, these surviving 721.221 cells showed substantially decreased expression of CD80 (see Fig. 10 , which is published as supporting information on the PNAS web site), the result of apparent in vitro selection for cells escaping CD28 mediated killing. Conversely, isolated LFA-1 signals did not trigger cytotoxicity of YTS cells or pNK cells.
Intriguingly, the functional difference between LFA-1 and CD28 was nicely paralleled by differences in ERK signaling: CD28 causes a sustained ERK2 phosphorylation lasting for Ϸ15 min, whereas LFA-1 triggers a rather transient ERK2 phosphorylation lasting for only 5 min. The duration of ERK signaling was known to be critical in modulating different cellular functions (23) . This linkage is particularly important, given the results showing that ERK2 signaling is important for the process of MTOC polarization and consequently granule polarization. Thus, the following pathway involved in MTOC movement can be proposed: CD28 3 PI3K 3 Rac1 3 PAK1 3 MEK1͞2 3 ERK2 3 MTOC movement, causing granule movement. Ligation of LFA-1 also induced a transient ERK phosphorylation, which was insufficient to induce MT reorganization, granule polarization (data not shown), or cytotoxicity (Figs. 2B and 6) in YTS or pNK cells. By contrast, a 1.8-fold increase in granule polarization without inducing cytotoxicity (that could be related to the transient ERK2 phosphorylation shown in Fig. 5A ) was recently reported as the result of ligation of LFA-1 on pNK cells by ICAM-1 expressed on insect cells (24) . Additional signaling pathways may be critical for MTOC movement, yet remain untriggered by LFA-1 ligation alone.
In a variety of cell types, the MAPK pathway is known as a critical regulator of MT functions (25) . However, the involvement of MAPK in MT remodeling is not fully understood. The evidence that ERK2 is required for the polarization of MTOC and that ERK colocalize to MT in NK cells indicates that ERK2 may regulate MT-associated motors and͞or MT-associated proteins. The activities of cytoplasmic dynein and paxillin have been suggested to depend on the phosphorylation of their serine and threonine residues (26, 27) , which could be phosphorylated by MAPK (28, 29) . Could ERK2 directly phosphorylate these proteins and thus be involved in the modulation of MTOC polarization? Interestingly, paxillin has been recently suggested to be a downstream regulator in the PI3K͞ERK pathway in cytotoxic T lymphocyte and thus involved in the activation of cytotoxicity (30) . Our parallel experiments have revealed that simultaneous activation of the PI3K-independent JNK MAPK pathway can activate paxillin and is also important in the process of MTOC and granule polarization in NK cells (B.G. and J.L.S., unpublished data). It is possible that ERK and JNK may phosphorylate different protein targets or different residues, all of which are required for this process.
Although these experiments were performed by using the YTS NK tumor cell line as a model system, they may be representative of most NK cells. First, IL-2-activated pNK cells also showed cytotoxic activity against B7 expressing targets (3, 5). Second, the YxxM motif, which recruits PI3K to CD28, is also present in the cytoplasmic domain of the more typical NK cell receptor NKG2D. Ligation of NKG2D has also been suggested to activate the PI3K, Rac, PAK, MEK, and ERK pathway and granule movement (14) . One can hypothesize that NKG2D signaling similarly regulates MTOC movement. It will be interesting to examine the redundancies and individual roles of CD2, NKp46, NKp44, NKp30, DNAM-1, and others, in the regulation of the different physical steps necessary for a NK cell to become a killer.
Materials and Methods
Abs and Reagents. The following Abs were used: anti-LFA-1 mAb (clones TS1͞18 and TS1͞22; gifts from T. Springer, Harvard Medical School, Boston), anti-CD28 (clone 28.2 from eBioscience, San Diego; clone L293 from BD Biosciences, Franklin Lakes, NJ; and clone YTH293.2 from Serotec), anti-human MHC I (clone ME1, biotin-conjugated), anti-pan ERK1͞2 (rabbit polyclonal; Upstate Biotechnology, Lake Placid, NY), anti-pan ERK1͞2 (clone 16; BD Biosciences), anti-phospho-ERK mAb (cloneE10, both purified and Alexa Fluor 488-conjugated from Cell Signaling Technology, Beverly, MA; clone 20A, Alexa Fluor 647-conjugated, from BD Biosciences), anti-␤-tubulin (clone tub2.1, Cy3-conjugated; Sigma-Aldrich), anti-GB (clone GB11, Alexa Fluor 647-conjugated; BD Biosciences), anti-rabbit IgG [clone RG-96, horseradish peroxidase (HRP)-conjugated; Sigma-Aldrich], antimouse IgG (HRP-conjugated, Sigma-Aldrich, anti-mouse IgG (Alexa Fluor 568-conjugated; Molecular Probes). All other Abs were from BD Biosciences. Phalloidin (Alexa Fluor 488-conjugated) was obtained from Molecular Probes. Kinase inhibitors wortmannin, LY294002, PD98059 inhibitor, and TAT-MEK13 pseudosubstrate inhibitor were from Calbiochem. All other chemicals were from Sigma-Aldrich, unless stated otherwise. The Annexin-V and propidium iodide (PI) staining kit was purchased from BD Biosciences.
Plasmids and Construct Generation. DNA plasmids pcDNA3-ICAM-1 and pcDNA3-ICAM-2 were constructed by PCR from ICAM-1͞2 constructs (gifts from T. Springer) with primer pairs 5Ј-TTTGGATCCATGGCTCCCAGCAGCCCC-3Ј and 5Ј-TTT-TCTAGATCAGGGAGGCGTGGCTTG-3Ј for the ICAM-1 gene, and 5Ј-TTTGGATCCATGTCCTCTTTCGGTTAC- With the ligand-expressing P815 transfectants as the targets, IL-2 activated NK cells were used in a 51 Cr-release cytotoxicity assay. The percentage of target cells lysed at different effector:target ratios is summarized. ND, not determined. The Student t test was used to prove that CD80-and CD86-transfected P815 targets induced statistically significant enhancement in cytotoxicity (P Ͻ 0.005; bold type). However, CD54-and CD102-transfected targets did not (P Ͼ 0.01). The killing assays were performed with pNK cells from six different donors (A-F) at indicated effector͞target ratios.
